Register for the Webinar to Learn More.
With more ADCs and bioconjugates entering late-stage development, demand for commercial-scale manufacturing is rising. Commercializing ADCs and bioconjugates requires interdisciplinary expertise spanning both biologics and small-molecule development—expertise that individual biopharmaceutical companies may not always possess. These challenges, combined with accelerated development timelines, increase the complexity of ADC and bioconjugate development and commercial manufacturing.
In this webinar, we will discuss strategies to address these challenges and to enable high-quality ADC and bioconjugate manufacturing. We will introduce how to support growth of ADC and bioconjugates across the industry and enable success worldwide.
Key learning objectives include:
- Key considerations in ADC & bioconjugate manufacturing
- Integrated approaches to overcome top challenges
- The importance of a global dual-sourcing strategy, with an exciting look at the WuXi XDC Singapore site
- Benchmark cases on the empowerment of partnerships
Offered Free by: Wuxi XDC
See All Resources from: Wuxi XDC
